Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables

被引:63
作者
Donadieu, J
Auclerc, MF
Baruchel, A
Leblanc, T
Landman-Parker, J
Perel, Y
Michel, G
Cornu, G
Bordigoni, P
Sommelet, D
Leverger, G
Hill, C
Schaison, G
机构
[1] Inst Gustave Roussy, Dept Biostat & Epidemiol, F-94805 Villejuif, France
[2] Hop St Louis, Serv Hematol Pediat, Paris, France
[3] Hop Trousseau, Serv Hematooncol Pediat, F-75571 Paris, France
[4] Hop Pellegrin, Serv Hematooncol Pediat, F-33076 Bordeaux, France
[5] Hop Enfants La Timone, Serv Hematol Pediat, Marseille, France
[6] Fac Med Louvain, Dept Hematol Infantile, Brussels, Belgium
[7] Hop Brabois, Serv Med Infantile 2, Nancy, France
关键词
acute lymphoblastic leukaemia; childhood; prognostic factors; proportion of explained variation;
D O I
10.1046/j.1365-2141.1998.00818.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined the proportion of survival variability explained by the usual prognostic factors in childhood acute lymphoblastic leukaemia (ALL) during a prognostic study of 1552 patients enrolled in three consecutive Fralle group protocols (Fralle 83, Fralle 87 and Fralle 89), The event-free survival rates at 5 years were 54.8% (SD 1.9), 43.1% (SD 2.7) and 55.6% (SD 2.2), respectively. In the univariate analysis the following variables were predictive of poor outcome: male gender, elevated leucocytosis (> 50 x 10(9)/l), circulating blastosis, haemoglobin >12 g/dl, platelet count <100 x 10(9)/l, age under 1 year or over 9 years, enlarged mediastinum, nodes, spleen and liver, T phenotype, absence of CD10(+) cells; testicular and meningeal involvement, poor response to induction therapy (CCSG M3), and LDH >400 U/l. Among the cytogenetic features, hyperdiploidy had a protective effect, whereas hypodiploidy, translocation and other structural abnormalities had a negative influence, particularly in cases of t(9;22) or t(4;11). Multivariate analysis summarized the prognostic information in terms of four variables: age, gender, leucocytosis and cytogenetic features. Missing data had little influence on the results. However, despite their significance in the multivariate analysis, these four variables each had very low predictive power (1.1% for gender, 2.0% for age, 3.5% for leucocytosis, and 1.6% for cytogenetic features). Thus, the most significant prognostic factors in childhood ALL each explain no more than 4% of the variability in prognosis, This may explain the disappointing practical value of these factors and underlines the need for prognostic tools in childhood ALL.
引用
收藏
页码:729 / 739
页数:11
相关论文
共 63 条
[1]  
AHNERENNASSIH E, 1995, ANN HEMATOL, V70, P131
[2]  
ARICO M, 1995, CANCER, V75, P1684, DOI 10.1002/1097-0142(19950401)75:7<1684::AID-CNCR2820750720>3.0.CO
[3]  
2-2
[4]   DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA - METHODOLOGIC ADVANCES AND CLINICAL-SIGNIFICANCE [J].
CAMPANA, D ;
PUI, CH .
BLOOD, 1995, 85 (06) :1416-1434
[5]   INTENSIFICATION OF TREATMENT AND SURVIVAL IN ALL CHILDREN WITH LYMPHOBLASTIC-LEUKEMIA - RESULTS OF UK MEDICAL-RESEARCH-COUNCIL TRIAL UKALL-X [J].
CHESSELLS, JM ;
BAILEY, C ;
RICHARDS, SM ;
EDEN, OB ;
BARBOR, PRH ;
BARRETT, A ;
BARTON, C ;
BROADBENT, V ;
DEMPSEY, SI ;
DURRANT, J ;
EMERSON, P ;
EVANS, DIK ;
FENNELLY, JJ ;
GALTON, DAG ;
GIBSON, B ;
GRAY, R ;
HANN, IM ;
HARDISTY, RM ;
HILL, FGH ;
KERNAHAN, J ;
KING, DJ ;
LILLEYMAN, JS ;
MANN, J ;
MARTIN, J ;
MCELWAIN, TJ ;
MELLOR, ST ;
JONES, PHM ;
OAKHILL, A ;
PETO, J ;
RADFORD, M ;
REES, JKH ;
STEVENS, RF ;
SUMMERFIELD, GP ;
THOMPSON, EN .
LANCET, 1995, 345 (8943) :143-148
[6]  
Collet D., 1994, MODELLING SURVIVAL D, V1st
[7]  
CORTES JE, 1995, CANCER-AM CANCER SOC, V76, P2393, DOI 10.1002/1097-0142(19951215)76:12<2393::AID-CNCR2820761203>3.0.CO
[8]  
2-P
[9]   CLINICAL AND BIOLOGIC FEATURES PREDICT POOR PROGNOSIS IN ACUTE LYMPHOID LEUKEMIAS IN CHILDREN AND ADOLESCENTS - A PEDIATRIC ONCOLOGY GROUP REVIEW [J].
CRIST, W ;
BOYETT, J ;
PULLEN, J ;
VANEYS, J ;
VIETTI, T .
MEDICAL AND PEDIATRIC ONCOLOGY, 1986, 14 (03) :135-139
[10]  
CRIST W, 1990, BLOOD, V76, P489